Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: A prospective study in northern Sweden

Gut

Volumn 50, Issue 5, 2002, Pages 642-646

  Palmqvist, R ^a   Hallmans, G ^a   Rinaldi, S ^a   Biessy, C ^a   Stenling, R ^a   Riboli, E ^a   Kaaks, R ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; COLON MUCOSA; COLORECTAL CANCER; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; ENERGY BALANCE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITOGENICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEDEN;

ADULT; ANTHROPOMETRY; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ODDS RATIO; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS;

EID: 0036112482     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.5.642     Document Type: Article

References (35)

1. The role of the insulin-like growth factor system in human cancer
2. Insulin and colon cancer
3. Insulin-like growth factors and binding proteins in colan cancer
4. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
5. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha
6. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-1 I-mediated autocrine loop
7. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
8. Increased epithelial cell proliferation in the colon of patients with acromegaly
9. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly
10. Mortality and cancer incidence in acromegaly: A retrospective cohort study
11. Acromegaly, colonic polyps and carcinoma
12. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly
13. Insulin-like growth factors and their binding proteins: Biological actions
14. Nutritional regulation of the insulin-like growth factors
15. Energy balance and cancer: The role of insulin and insulin-like growth factor-I
16. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
17. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women
18. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
19. The PHREG procedure
20. IGF-1 and IGF-11 in relation to colorectal cancer
21. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells
22. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
23. Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells
24. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?
25. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
26. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
27. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
28. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
29. Serum insulin-like growth factor-I and breast cancer
30. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-1) axis: Predominant impact of age, obesity, gonadal function, and sleep
31. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age
32. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
33. Evaluation of disease activity by IGF-1 and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score
34. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
35. Insulin-like growth factor I (IGF-1), IGF-binding protein-3 and prostate cancer risk: Epidemiological studies